CA2532865A1 — Fluoro substituted omega-carboxyaryl diphenyl urea for the inhibition of kinase signaling
Assigned to Bayer Healthcare LLC · Expires 2005-02-03 · 21y expired
What this patent protects
A compound of Formula (I): (see formula I) salts thereof, metabolites thereof, pharmaceutical compositions containing such a compound, and use of such compound and compositions for inhibition of abnormal raf, VEGFR, PDGFR, p38 and/or flt-3.
USPTO Abstract
A compound of Formula (I): (see formula I) salts thereof, metabolites thereof, pharmaceutical compositions containing such a compound, and use of such compound and compositions for inhibition of abnormal raf, VEGFR, PDGFR, p38 and/or flt-3.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.